Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yi-Ze Zhang"'
Autor:
Yi-Ze Zhang, Xi Chen, Xing-Xing Fan, Jian-Xing He, Jun Huang, Da-Kai Xiao, Yan-Ling Zhou, Sen-You Zheng, Jia-Hui Xu, Xiao-Jun Yao, Liang Liu, Elaine Lai-Han Leung
Publikováno v:
Molecules, Vol 21, Iss 3, p 374 (2016)
Non-small-cell lung cancer (NSCLC) dominates over 85% of all lung cancer cases. Epidermal growth factor receptor (EGFR) activating mutation is a common situation in NSCLC. In the clinic, molecular-targeting with Gefitinib as a tyrosine kinase inhibit
Externí odkaz:
https://doaj.org/article/ba2a492837a942679495075a91530fe1
Publikováno v:
In Chinese Astronomy and Astrophysics April-June 2020 44(2):258-268
Autor:
Fu Gang Duan, Robin J. Parks, Benjamin K. Tsang, Elaine Lai-Han Leung, Xing-Xing Fan, Meifang Wang, Xiao-Jun Yao, Liang Liu, Chae Young Han, Yi-Ze Zhang, Yijun Tang
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-13 (2019)
Cancer Cell International
Cancer Cell International
Background Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths primarily due to chemoresistance. Somatic mutation of TP53 (36%) and epidermal growth factor receptor (EGFR; > 30%) are major contributors to cisplatin (CDDP) resista
Autor:
Hong-Bin Shen, Yi-Ze Zhang
Publikováno v:
Journal of chemical information and modeling. 57(4)
Signal peptides play key roles in targeting and translocation of integral membrane proteins and secretory proteins. However, signal peptides present several challenges for automatic prediction methods. One challenge is that it is difficult to discrim
Autor:
Hong-Bin Shen, Yi-Ze Zhang
Publikováno v:
CISP-BMEI
Signal peptides are significant important in targeting the translocation of integral membrane proteins and secretory proteins. Due the high similarity between the transmembrane helices and signal peptides, classifiers have limit ability to discrimina
Autor:
Liang Liu, Xi Chen, Jun Huang, Xiao-Jun Yao, Yan-Ling Zhou, Da-Kai Xiao, Sen-You Zheng, Elaine Lai-Han Leung, Yi-Ze Zhang, Jiahui Xu, Xing-Xing Fan, Jianxing He
Publikováno v:
Molecules
Molecules; Volume 21; Issue 3; Pages: 374
Molecules, Vol 21, Iss 3, p 374 (2016)
Molecules; Volume 21; Issue 3; Pages: 374
Molecules, Vol 21, Iss 3, p 374 (2016)
Non-small-cell lung cancer (NSCLC) dominates over 85% of all lung cancer cases. Epidermal growth factor receptor (EGFR) activating mutation is a common situation in NSCLC. In the clinic, molecular-targeting with Gefitinib as a tyrosine kinase inhibit
Autor:
Yi-Ze Zhang, Hong-Bin Shen
Publikováno v:
Journal of Chemical Information & Modeling; Apr2017, Vol. 57 Issue 4, p988-999, 12p